U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07409506) titled 'Assessment of Informal Support Provided by Caregivers at Different Stages of Alzheimer's Disease' on Dec. 16, 2025.
Brief Summary: In France, approximately 1,200,000 people aged 65 and over suffer from Alzheimer's disease or related disorders, of which Alzheimer's disease (AD) accounts for 70% of cases. This prevalence could double by 2050. The cognitive decline and progression to functional dependence that accompany AD are associated with a decline in quality of life, an increased risk of comorbidities, institutionalization, and mortality, as well as high care costs, placing a burden on the patient, their family and friends, and th...